Enliven Therapeutics
ELVN
ELVN
125 hedge funds and large institutions have $959M invested in Enliven Therapeutics in 2025 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 46 increasing their positions, 45 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
27% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 26
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
73% less call options, than puts
Call options by funds: $203K | Put options by funds: $765K
Holders
125
Holding in Top 10
2
Calls
$203K
Puts
$765K
Top Buyers
| 1 | +$53.2M | |
| 2 | +$20.4M | |
| 3 | +$9.25M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$8.34M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$5.26M |
Top Sellers
| 1 | -$19.4M | |
| 2 | -$16M | |
| 3 | -$8.19M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$8.17M |
| 5 |
Blackstone Inc
New York
|
-$7.28M |
